Zou Xiangman, Liu Zhi, Song Fengnan, Zhou Wei, Hang Jiaying, Feng Chenchen, Yuan Tianhong, Dong Jinhua, Shi Wei, Tang Feng, Huang Wei
Key Laboratory of Structure-Based Drug Design and Discovery (Ministry of Education), Shenyang Pharmaceutical University, Shenyang, China.
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Commun Biol. 2025 Aug 6;8(1):1165. doi: 10.1038/s42003-025-08614-7.
The removal of N-terminal methionine (Met) or fused N-terminal purification tags to expose the first amino acid of the target protein is critically important for studying the potential regulatory role of the N-terminal residue. However, current tag-removal approaches typically rely on enzymatic cleavage or require harsh reaction conditions. Here, we report a strategy for expressing proteins of interest (POI) with custom N-terminal amino acids by introducing an engineered cysteine protease domain (CPD) tag at the N-terminus. The cleavable tag is chemically triggered by inositol hexakisphosphate (InsP), enabling precise generation of proteins with a user-defined N-terminus. Through systemic design and engineering of the N-terminal CPD tag, we successfully achieved POI variants with N-terminal Gly, Ser, His, Lys and other residues except Pro. In addition to the model protein, a Her2-targeting nanobody, we also successfully produced a RNF43-specific nanobody with an N-terminal Gln (N-Gln), an EGFR-targeting nanobody with N-Ala, the Sortase A enzyme with N-Gln, the fluorescent protein TurboGFP with N-Glu, and the sialic acid transferase Δ15 Pd2,6ST with N-Cys. The construction of engineered nCPD-His10-POI further produced POI variants with a customized N-terminus and without any purified tags. Overall, the established approach enables high-yield protein expression and enzyme-independent, single-step removal of the redundant tag to yield proteins with the desired N-terminal residues, offering a valuable option for investigating N-terminal modifications and their functional implications.
去除N端甲硫氨酸(Met)或融合的N端纯化标签以暴露目标蛋白的首个氨基酸对于研究N端残基的潜在调节作用至关重要。然而,目前的标签去除方法通常依赖酶切或需要苛刻的反应条件。在此,我们报告了一种通过在N端引入工程化半胱氨酸蛋白酶结构域(CPD)标签来表达具有定制N端氨基酸的目的蛋白(POI)的策略。可裂解标签由肌醇六磷酸(InsP)化学触发,能够精确生成具有用户定义N端的蛋白质。通过对N端CPD标签进行系统设计和工程改造,我们成功获得了N端为Gly、Ser、His、Lys以及除Pro以外其他残基的POI变体。除了模型蛋白Her2靶向纳米抗体外,我们还成功制备了N端为Gln(N-Gln)的RNF43特异性纳米抗体、N端为Ala的EGFR靶向纳米抗体、N端为Gln的分选酶A、N端为Glu的荧光蛋白TurboGFP以及N端为Cys的唾液酸转移酶Δ15 Pd2,6ST。工程化nCPD-His10-POI的构建进一步产生了具有定制N端且无任何纯化标签的POI变体。总体而言,所建立的方法能够实现高产蛋白表达,并在不依赖酶的情况下一步去除多余标签,从而产生具有所需N端残基的蛋白质,为研究N端修饰及其功能意义提供了一个有价值的选择。